Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,226,400 | 1,227,000 | 818,300 | 630,300 | 508,200 |
| Marketable Securities | 174,400 | 272,300 | 519,200 | 772,500 | 623,600 |
| Receivables | 520,100 | 446,800 | 479,300 | 475,000 | 510,700 |
| Inventories | 568,100 | 573,900 | 554,900 | 538,400 | 491,600 |
| Other current assets | 137,100 | 118,900 | 116,900 | 97,400 | 95,200 |
| TOTAL | $2,696,000 | $2,716,900 | $2,549,200 | $2,566,400 | $2,283,400 |
| Non-Current Assets | |||||
| PPE Net | 770,200 | 711,600 | 679,700 | 649,600 | 627,900 |
| Investments And Advances | 470,400 | 532,100 | 567,000 | 567,500 | 551,500 |
| Intangibles | 1,584,600 | 1,625,300 | 1,594,500 | 1,395,400 | 1,373,700 |
| Other Non-Current Assets | 164,900 | 239,200 | 276,000 | 309,500 | 302,000 |
| TOTAL | $2,990,100 | $3,108,200 | $3,117,200 | $2,922,000 | $2,855,100 |
| Total Assets | $5,686,100 | $5,825,100 | $5,666,400 | $5,488,400 | $5,138,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 599,200 | 598,600 | 598,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 584,000 | 674,100 | 116,600 | 693,700 | 562,500 |
| Accrued Expenses | N/A | N/A | 653,700 | N/A | N/A |
| Other current liabilities | N/A | 41,800 | 51,700 | 41,500 | N/A |
| TOTAL | $1,446,500 | $1,314,500 | $1,420,000 | $735,200 | $562,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 593,900 | 456,000 | 438,400 | 1,034,000 | 1,016,800 |
| aiOther Non-Current Liabilities | 481,500 | 808,900 | 851,800 | 556,700 | 619,600 |
| TOTAL | $1,075,400 | $1,264,900 | $1,290,200 | $1,590,700 | $1,636,400 |
| Total Liabilities | $2,521,900 | $2,579,400 | $2,710,200 | $2,325,900 | $2,198,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 628,158 | 632,337 | 630,071 | 634,860 | 633,474 |
| Common Shares | 214,000 | 213,000 | 212,000 | 211,600 | 244,700 |
| Retained earnings | 2,461,800 | 2,179,100 | 1,962,100 | 1,964,900 | 4,331,900 |
| Other shareholders' equity | -151,100 | -121,500 | -132,800 | -142,500 | -158,000 |
| TOTAL | $3,164,200 | $3,245,700 | $2,956,200 | $3,162,500 | $2,939,600 |
| Total Liabilities And Equity | $5,686,100 | $5,825,100 | $5,666,400 | $5,488,400 | $5,138,500 |